Literature DB >> 15568749

[The expression and interaction of cyclin D1 and p16 in fibroblasts of pathologic scars].

Jia-Feng Liu1, Yi-Ming Zhang, Chuan-Xun Yi, Jia-Ming Sun, Wei-Wei Li.   

Abstract

OBJECTIVE: To investigate the expression of cyclin D1, p16, AR and ER in fibroblasts of scars for further understanding the interaction of these factors and the roles that they play in scar development.
METHODS: Thirty samples of mature scar, hypertrophic scar and keloid were detected with immunohistochemical method (SP technique) and compared with normal skin.
RESULTS: There were on positive results in normal skin and mature scars. The expression of cyclin D1, p16 and AR was higher in hypertrophic scars and keloids than in normal skin with significant difference (P < 0.05). The expression of cyclin D1 in keloids was higher than in hypertrophic scars (P < 0.05). Though the expression of p16 was higher in keloids than in hypertrophic scars, the difference was not significant. There was significant correlation between the expression of cyclin D1 and AR in the pathologic scar.
CONCLUSION: The AR played an important role in scar formation and displayed its function through cyclin D1. The expression of p16 could suppress the excessive proliferation of cells to some extent. If the effect was not enough to resist the function of cyclin D1, long-term proliferation of cells would occur and lead to keloid formation. As the expression of cyclin D1 and p16 in hypertrophic scars was in a state of relative equilibrium, the cell proliferation showed a tendency of self-restriction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568749

Source DB:  PubMed          Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi        ISSN: 1009-4598


  2 in total

1.  miR-4417 suppresses keloid fibrosis growth by inhibiting CyclinD1.

Authors:  Pei Liu; Yaotian Hu; Lin Xia; Min DU; Zhensheng Hu
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

2.  The expression of P16 and S100 associated with elastin degradation and fibrosis of the Ligamentum Flavum hypertrophy.

Authors:  Wei Hu; Shunli Kan; Guang Liu; Zegang Cao; Rusen Zhu
Journal:  BMC Musculoskelet Disord       Date:  2019-10-22       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.